New shot aims to reverse cervical precancer without surgery
Disease control
Not yet recruiting
This early-stage trial tests an injection called BBM-C101 in 60 women with high-grade cervical precancer linked to HPV16 or HPV18. The goal is to see if the drug is safe and can shrink or eliminate abnormal cells, potentially offering a non-surgical alternative. Participants rece…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Mianyi Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC